Ebola Vaccine Trial Begins In DR Congo – WHO Chief
The DR Congo's worst-ever Ebola outbreak has passed the 9,700-case mark, with the number of deaths exceeding 4,600. The post Ebola Vaccine Trial Begins In DR Congo – WHO Chief appeared first on Channels Television.
The Democratic Republic of Congo has been battling its worst-ever Ebola outbreak, a crisis complicated by armed conflict in the eastern regions, community mistrust of health workers, and attacks on treatment centres that have hampered containment efforts. Ebola, a viral haemorrhagic fever first identified in the 1970s near the Ebola River, spreads through contact with bodily fluids and has historically carried high fatality rates, making vaccines and rapid response critical to controlling flare-ups across Central and West Africa.
The World Health Organisation has led international response efforts in the DRC, including deploying an experimental vaccine that had shown promise in earlier outbreaks, notably West Africa's 2014-2016 epidemic. The newsrooms covering this latest development agree on the central fact: a clinical trial for an Ebola vaccine has begun amid the ongoing outbreak. Punch adds a specific detail — that the trial targets the Bundibugyo strain of the virus — while other outlets provide broader context on the scale of the crisis. Details such as trial duration, number of participants, and when results might inform wider vaccination strategy have not yet been reported.